Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FE3U1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $119,075
Award facts
- Contract value 100% obligated
- $119,074.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $119,074.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion by September 2, 2025. This is a non-set-aside, competitively awarded contract reflecting AmerisourceBergen's established capability as a critical pharmaceutical distributor within the federal medical supply chain. The award represents a child delivery order issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Enbrel is a biologic immunosuppressant used primarily for rheumatoid arthritis and other autoimmune conditions, and this delivery supports federal medical procurement needs across defense healthcare systems including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's portfolio of DLA awards demonstrates extensive experience delivering specialty medications, biologics, and medical supplies across multiple therapeutic domains to military and veteran healthcare systems. The firm fixed-price delivery order structure, consistent with AmerisourceBergen's federal contract pattern, ensures cost predictability while leveraging the company's established supply chain capabilities within the broader Pharmaceutical Prime Vendor Global Program framework.
Quick answers
Who was awarded contract SPE2DB25FE3U1?
SPE2DB25FE3U1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FE3U1 worth?
The government has obligated $119,075 on SPE2DB25FE3U1.
Is contract SPE2DB25FE3U1 an order under another contract?
Yes. SPE2DB25FE3U1 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE3U1 competed?
The extent of competition for SPE2DB25FE3U1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award